These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. The antineutrophil cytoplasmic antibody-associated vasculitides. Seo P; Stone JH Am J Med; 2004 Jul; 117(1):39-50. PubMed ID: 15210387 [TBL] [Abstract][Full Text] [Related]
24. Infectious complications of immunosuppressive treatment for anti-neutrophil cytoplasm antibody-related vasculitis. Koselj-Kajtna M; Koselj M; Rott T; Kandus A; Bren A Transplant Proc; 2002 Nov; 34(7):3001-2. PubMed ID: 12431683 [No Abstract] [Full Text] [Related]
25. [Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis (CYCLOPS study)]. Kötter I Z Rheumatol; 2009 Sep; 68(7):575-7. PubMed ID: 19652987 [No Abstract] [Full Text] [Related]
26. Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis. De Groot K; Rasmussen N; Bacon PA; Tervaert JW; Feighery C; Gregorini G; Gross WL; Luqmani R; Jayne DR Arthritis Rheum; 2005 Aug; 52(8):2461-9. PubMed ID: 16052573 [TBL] [Abstract][Full Text] [Related]
27. What is new in systemic vasculitis? Kallenberg CG; Tervaert JW Ann Rheum Dis; 2000 Nov; 59(11):924-5. PubMed ID: 11053075 [No Abstract] [Full Text] [Related]
28. Pulse versus daily oral cyclophosphamide in ANCA-associated vasculitis. Hebert LA; Rovin BH Ann Intern Med; 2010 Jan; 152(1):64; author reply 65. PubMed ID: 20048278 [No Abstract] [Full Text] [Related]
29. BSR and BHPR guidelines for the management of adults with ANCA associated vasculitis. Lapraik C; Watts R; Bacon P; Carruthers D; Chakravarty K; D'Cruz D; Guillevin L; Harper L; Jayne D; Luqmani R; Mooney J; Scott D; Rheumatology (Oxford); 2007 Oct; 46(10):1615-6. PubMed ID: 17804455 [No Abstract] [Full Text] [Related]
30. Anti-neutrophil cytoplasmic antibody (ANCA) levels directed against proteinase-3 and myeloperoxidase are helpful in predicting disease relapse in ANCA-associated small-vessel vasculitis. Stegeman CA Nephrol Dial Transplant; 2002 Dec; 17(12):2077-80. PubMed ID: 12454214 [No Abstract] [Full Text] [Related]
31. Maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies. Sanders JS; Slot MC; Stegeman CA N Engl J Med; 2003 Nov; 349(21):2072-3; author reply 2072-3. PubMed ID: 14627795 [No Abstract] [Full Text] [Related]